Burning Rock Biotech Ltd. ADR (BNR) Social Stream
BURNING ROCK BIOTECH LTD (BNR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BNR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-25 | 3 | $36.1 | $27.5 | $31.8 | $0.924 | 3341.56% |
| 2021-12-06 | 3 | $36.1 | $23 | $29.55 | $0.924 | 3098.05% |
| 2022-01-06 | 3 | $26.7 | $23 | $24.85 | $0.924 | 2589.39% |
| 2022-03-17 | 3 | $26.7 | $13.5 | $20.1 | $0.924 | 2075.32% |
| 2022-03-23 | 3 | $26.7 | $13 | $19.85 | $0.924 | 2048.27% |
| 2022-03-25 | 3 | $13 | $12.8 | $12.9 | $0.924 | 1296.1% |
| 2022-08-13 | 3 | $12.8 | $6.7 | $9.75 | $0.924 | 955.19% |
| 2022-09-26 | 3 | $10.8 | $6.7 | $8.75 | $0.924 | 846.97% |
| 2023-01-26 | 3 | $10.8 | $3.8 | $7.3 | $0.924 | 690.04% |
| 2023-03-29 | 1 | $8.9 | $8.9 | $8.9 | $0.924 | 863.2% |
| 2023-05-16 | 2 | $8.9 | $3.8 | $6.35 | $0.924 | 587.23% |
| 2023-09-01 | 1 | $7.3 | $7.3 | $7.3 | $0.924 | 690.04% |
| 2023-09-22 | 1 | $0.9 | $0.9 | $0.9 | $0.924 | -2.6% |
The Trend in the Analyst Price Target
Over the past 34 months, BNR's average price target has gone down $31.2.
BNR reports an average of 157.72% for its upside potential over the past 34 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 2 | 10.8 | 3.8 | 7.30 | 3.17 | 130.28% |
| 2023-01-26 | 3 | 10.8 | 3.8 | 7.30 | 3.17 | 130.28% |
| 2023-03-29 | 1 | 8.9 | 8.9 | 8.90 | 2.90 | 206.9% |
| 2023-03-29 | 2 | 8.9 | 8.9 | 8.90 | 2.90 | 206.9% |
| 2023-05-16 | 2 | 8.9 | 3.8 | 6.35 | 2.82 | 125.18% |
BNR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 35 weeks, BNR's average broker recommendation rating worsened by 2.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BNR as an investment opportunity.
- BNR has a greater upside potential (average analyst target price relative to current price) than 1388.57% of all US stocks.
- In the context of all US stocks, BURNING ROCK BIOTECH LTD's number of analysts covering the stock is higher than 79.46% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, BURNING ROCK BIOTECH LTD's variance in analysts' estimates is lower than -611.68% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, BURNING ROCK BIOTECH LTD's average analyst price target is greater than 287.87% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to BURNING ROCK BIOTECH LTD are GTH, CANO, and SGRY.
View All Top Stocks by Price Target
What is the outlook for BNR? Use POWR Ratings for clearer insight into price direction.